Subnormothermic machine perfusion protects steatotic livers against preservation injury: A potential for donor pool increase?

Liver Transplantation

Volumn 15, Issue 1, 2009, Pages 20-29

  Vairetti, Mariapia ^a   Ferrigno, Andrea ^a   Carlucci, Filippo ^b   Tabucchi, Antonella ^b   Rizzo, Vittoria ^a   Boncompagni, Elenora ^a   Neri, Daniele ^c   Gringeri, Enrico ^c   Freitas, Isabel ^a   Cillo, Umberto ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; GAMMA GLUTAMYLTRANSFERASE; GLYCOGEN; INOSINE PHOSPHATE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE FLOW; CELL SURVIVAL; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME RELEASE; FATTY LIVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOCHEMISTRY; LIVER PERFUSION; LIVER PRESERVATION; MALE; NONHUMAN; ORGAN DONOR; OXYGENATION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; STORAGE TEMPERATURE; ZUCKER RAT;

ACETYLCYSTEINE; ANIMALS; BILE; CELL SURVIVAL; FATTY LIVER; GLUCOSE; GLYCOGEN; LIVER; MALE; ORGAN PRESERVATION; PERFUSION; RATS; RATS, ZUCKER; REACTIVE OXYGEN SPECIES; TEMPERATURE; TISSUE DONORS;

EID: 64049110277     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21581     Document Type: Article

References (41)

1. Bessems M, Doorschodt BM, van Marle J, Vreeling H, Meijer AJ, van Gulik TM. Improved machine perfusion preservation of the non-heart-beating donor rat liver using Polysol: a new machine perfusion preservation solution. Liver Transpl 2005;11:1379-1388.
2. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-1251.
3. Nocito A, El-Badry AM, Clavien PA. When is steatosis too much for transplantation? J Hepatol 2006;45:494-499.
4. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transplant Proc 1997;29:412-415.
5. Niemann CU, Hirose R, Liu T, Behrends M, Brown JL, Kominsky DF, et al. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth Analg 2005;101:1577-1583.
6. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993;56:1076-1082.
7. Bessems M, Doorschodt BM, Kolkert JL, Vetelainen RL, van Vliet AK, Vreeling H, et al. Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation. Liver Transpl 2007;13:497-504.
8. Yuxin C, Motomichi S, Yasuaki K, Yuji W, Kanji K. Perfusion and cold injury play an important role in liver preservation. Transplant Proc 1998;30:3688-3691.
9. Stammler L, Reichen J, Oehler R, Bianchi L, Landmann L. Decreased hepatocellular volume and intact morphology of tight junctions in calcium deprivation-induced cholestasis. Stereological and multiple indicator dilution analysis. J Hepatol 1990;10:318-326.
10. Bessems M, Doorschodt BM, van Vliet AK, van Gulik TM. Preservation of rat livers by cold storage: a comparison between the University of Wisconsin solution and Hypothermosol. Ann Transplant 2004;9:35-37.
11. Ben Mosbah I, Rosello-Catafau J, Franco-Gou R, Abdennebi HB, Saidane D, Ramella-Virieux S, et al. Preservation of steatotic livers in IGL-1 solution. Liver Transpl 2006; 12:1215-1223.
12. Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990;345:161-163.
13. Vairetti M, Richelmi P, Bertè F, Currin RT, Lemasters JJ, Imberti R. Role of pH in protection by low sodium against hypoxic injury in isolated perfused rat livers. J Hepatol 2006;44:894-901.
14. Bergmeyer HU, Bernt E, Hess B. Lactic dehydrogenase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York, NY: Academic Press; 1965:736-743.
15. Lowry HO, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;53:265-275.
16. Carlucci F, Tabucchi A, Biagioli B, Simeoni F, Scolletta S, Rosi F, Marinello E. Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia-reperfusion. Biomed Pharmacother 2002;56:483-491.
17. Davies CA, Perrett D, Zhang Z, Nielsen BR, Blake DR, Winyard PG. Simultaneous analysis of nitrite, nitrate and the nicotinamide nucleotides by capillary electrophoresis: application to biochemical studies and human extracellular fluids. Electrophoresis 1999;20:2111-2117.
18. Kerver ED, Vogels IM, Bosch KS, Vreeling-Sindelarova H, Van den Munckhof RJ, Frederiks WM. In situ detection of spontaneous superoxide anion and singlet oxygen production by mitochondria in rat liver and small intestine. Histochem J 1997;29:229-237.
19. Szocs K. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys 2004;23:265-295.
20. Vajdova K, Smrekova R, Kukan M, Lutterova M, Wsolova L. Bile analysis as a tool for assessing integrity of biliary epithelial cells after cold ischemia-reperfusion of rat livers. Cryobiology 2000;41:145-152.
21. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-470.
22. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 2006;91:807-819.
23. Freitas I, Bertone V, Guarnaschelli C, Ferrigno A, Boncompagni E, Rizzo V, et al. In situ demonstration of improvement of liver mitochondria function by melatonin after cold ischemia. In Vivo 2006;20:229-237.
24. Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 2000; 31:255-260.
25. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999;67:195-200.
26. Fujita S, Hamamoto I, Nakamura K, Tanaka K, Ozawa K. Evaluation of oxygen necessity during hypothermic liver perfusion. Nippon Geka Hokan 1993;62:228-240.
27. Han J, Paik YH, Yu JH, Kim H. Antioxidant nutrients inhibit LPS-induced IL-8 expression in human hepatic stellate cells. FASEB J 2007;21:855.8.
28. Nakano H, Nagasaki H, Barama A, Boudjema K, Jaeck D, Kumada K, et al. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet. Hepatology 1997;26:670-678.
29. Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990;345:161-163.
30. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-1857.
31. Ametani MS, D'Alessandro AM, Southard JH. The effect of calcium in the UW solution on preservation of the rat liver. Ann Transplant 1997;2:34-38.
32. Dutkowski P, Wahl W, Winkelbach V, Watzka M, Krysiak M, Junginger T. Calcium prevents loss of glutathione and reduces oxidative stress upon reperfusion in the perfused liver. Int J Surg Investig 2000;2:1-7.
33. Vairetti M, Ferrigno A, Rizzo V, Boncompagni E, Carraro A, Gringeri E, et al. Correlation between the liver temperature employed during machine perfusion and reperfusion damage: role of Ca2+. Liver Transpl 2008;14:494-503.
34. Morariu AM, Vd Plaats A, V Oeveren W, 'T Hart NA, Leuvenink HG, Graaff R, et al. Hyperaggregating effect of hydroxyethyl starch components and University of Wisconsin solution on human red blood cells: a risk of impaired graft perfusion in organ procurement? Transplantation 2003;76:37-43.
35. Feng XN, Xu X, Zheng SS. Current status and perspective of liver preservation solutions. Hepatobiliary Pancreat Dis Int 2006;5:490-494.
36. Lichtman SN, Lemasters JJ Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin Liver Dis 1999;19:171-187.
37. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
38. Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997;61: 647-653.
39. Kukan M, Haddad PS. Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl 2001;7:381-400.
40. Pizarro M, Balasubramaniyan N, Solis N, Solar A, Duarte I, Miquel JF, et al. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut 2004;53:1837-1843.
41. Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002;73:325-330.